Clovis Oncology, Inc. Operating Lease, Payments
Clovis Oncology, Inc. reported Operating Lease, Payments of $1.19 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-11-09
- Clovis Oncology, Inc. operating lease, payments for the quarter ending 2022-09-30 was $1.19M, a 11.70% decline year-over-year.
- Clovis Oncology, Inc. operating lease, payments for the quarter ending 2022-06-30 was $1.21M, a 5.70% decline year-over-year.
- Clovis Oncology, Inc. operating lease, payments for the quarter ending 2022-03-31 was $1.22M, a 3.03% decline year-over-year.
- Clovis Oncology, Inc. operating lease, payments for the quarter ending 2021-12-31 was $1.35M, a 7.93% increase year-over-year.
- Clovis Oncology, Inc. operating lease, payments for fiscal 2021 was $5.22M, a 12.35% increase from fiscal 2020.
- Clovis Oncology, Inc. operating lease, payments for fiscal 2020 was $4.65M, a 16.14% increase from fiscal 2019.
- Clovis Oncology, Inc. operating lease, payments for fiscal 2019 was $4.00M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.19M 10-Q · filed 2022-11-09 | $2.39M derived: sum of 2 quarters · filed 2022-11-09 | $3.61M 10-Q · filed 2022-11-09 | $4.96M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $1.21M 10-Q · filed 2022-08-08 | $2.42M 10-Q · filed 2022-08-08 | $3.77M derived: sum of 3 quarters · filed 2022-08-08 | $5.11M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $1.22M 10-Q · filed 2022-05-05 | $2.56M derived: sum of 2 quarters · filed 2022-05-05 | $3.90M derived: sum of 3 quarters · filed 2022-11-09 | $5.18M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.69M derived: sum of 2 quarters · filed 2022-11-09 | $3.97M derived: sum of 3 quarters · filed 2022-11-09 | $5.22M 10-K · filed 2022-02-24 |
| 2021-09-30 | $1.34M 10-Q · filed 2022-11-09 | $2.62M derived: sum of 2 quarters · filed 2022-11-09 | $3.88M 10-Q · filed 2022-11-09 | $5.12M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.28M 10-Q · filed 2022-08-08 | $2.53M 10-Q · filed 2022-08-08 | $3.78M derived: sum of 3 quarters · filed 2022-08-08 | $5.06M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-05 | $2.50M derived: sum of 2 quarters · filed 2022-05-05 | $3.78M derived: sum of 3 quarters · filed 2022-05-05 | $4.78M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.52M derived: sum of 2 quarters · filed 2022-02-24 | $3.52M derived: sum of 3 quarters · filed 2022-02-24 | $4.65M 10-K · filed 2022-02-24 |
| 2020-09-30 | $1.27M 10-Q · filed 2021-11-03 | $2.27M derived: sum of 2 quarters · filed 2021-11-03 | $3.40M 10-Q · filed 2021-11-03 | $4.59M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $998.00K 10-Q · filed 2021-08-04 | $2.12M 10-Q · filed 2021-08-04 | $3.32M derived: sum of 3 quarters · filed 2021-08-04 | $3.98M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $1.13M 10-Q · filed 2021-05-05 | $2.32M derived: sum of 2 quarters · filed 2021-05-05 | $2.98M derived: sum of 3 quarters · filed 2021-05-05 | $3.98M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.86M derived: sum of 2 quarters · filed 2021-02-25 | $2.85M derived: sum of 3 quarters · filed 2021-02-25 | $4.00M 10-K · filed 2021-02-25 |
| 2019-09-30 | $667.00K 10-Q · filed 2020-11-05 | $1.66M derived: sum of 2 quarters · filed 2020-11-05 | $2.81M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $994.00K 10-Q · filed 2020-08-07 | $2.14M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $1.15M 10-Q · filed 2020-05-06 |